Autologous bone marrow mesenchymal stem cell-derived neural progenitors (Tisch Multiple Sclerosis Research Center of New York)

自体骨髓间充质干细胞衍生神经祖细胞

Report date: 2025/04/09 17:57:53

Base Information

Drug NameAutologous bone marrow mesenchymal stem cell-derived neural progenitors (Tisch Multiple Sclerosis Research Center of New York)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Somatic cell > Neural progenitor cell therapy +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTisch Multiple Sclerosis Research Center Of New York

China Registration ClassN/A

Develop Information

Active CompaniesTisch Multiple Sclerosis Research Center Of New York

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A